Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Multi-site performance evaluation and Sigma metrics of 20 assays on the Atellica chemistry and immunoassay analyzers.

Fasano T, Bedini JL, Fle PA, Jlaiel M, Hubbert K, Datta H, Chicha-Cattoir V, Mansour H, Mira A, de la Presa BG, Rico N, de Pedro MS, Diaz-Garzon J, Buño Soto A, Vecchia L, Peoc'h K.

Clin Chem Lab Med. 2019 Oct 22. pii: /j/cclm.ahead-of-print/cclm-2019-0699/cclm-2019-0699.xml. doi: 10.1515/cclm-2019-0699. [Epub ahead of print]

PMID:
31639101
2.

Metals: common clinical applications in inductively coupled plasma mass spectrometry.

Cavey T, Ropert M, Loréal O, Bendavid C, Peoc'h K.

Ann Biol Clin (Paris). 2019 Oct 1;77(5):495-504. doi: 10.1684/abc.2019.1480.

PMID:
31638582
3.

Using transferrin saturation as a diagnostic criterion for iron deficiency: A systematic review.

Cacoub P, Vandewalle C, Peoc'h K.

Crit Rev Clin Lab Sci. 2019 Dec;56(8):526-532. doi: 10.1080/10408363.2019.1653820. Epub 2019 Sep 10.

4.

Biomarkers for acute mesenteric ischemia diagnosis: state of the art and perspectives.

Peoc'h K, Corcos O.

Ann Biol Clin (Paris). 2019 Aug 1;77(4):415-421. doi: 10.1684/abc.2019.1449.

PMID:
31225801
5.

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice.

Lehmann S, Paquet C, Malaplate-Armand C, Magnin E, Schraen S, Quillard-Muraine M, Bousiges O, Delaby C, Dumurgier J, Hugon J, Sablonnière B, Blanc F, Wallon D, Gabelle A, Laplanche JL, Bouaziz-Amar E, Peoc'h K; ePLM Group.

Clin Chim Acta. 2019 Aug;495:451-456. doi: 10.1016/j.cca.2019.04.081. Epub 2019 Apr 30.

PMID:
31051163
6.

Non-invasive biomarkers of fibrosis for the screening of patients with metabolic steatopathy (NAFLD) : a significant role for all biologists.

Peoc'h K, Castera L.

Ann Biol Clin (Paris). 2019 Apr 1;77(2):125-127. doi: 10.1684/abc.2019.1428. No abstract available.

PMID:
30998192
7.

Saving patient blood: a new rule of life? Focus on pre-operative anemia.

Peoc'h K.

Ann Biol Clin (Paris). 2019 Feb 1;77(1):7-9. doi: 10.1684/abc.2019.1417. No abstract available.

PMID:
30799302
8.

Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.

Peoc'h K, Nicolas G, Schmitt C, Mirmiran A, Daher R, Lefebvre T, Gouya L, Karim Z, Puy H.

Mol Genet Metab. 2019 Jan 23. pii: S1096-7192(18)30632-2. doi: 10.1016/j.ymgme.2019.01.015. [Epub ahead of print] Review.

PMID:
30737140
9.

Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.

Mirmiran A, Schmitt C, Lefebvre T, Manceau H, Daher R, Oustric V, Poli A, Lacapère JJ, Moulouel B, Puy H, Karim Z, Peoc'h K, Lenglet H, Simonin S, Deybach JC, Nicolas G, Gouya L.

Am J Hum Genet. 2019 Feb 7;104(2):341-347. doi: 10.1016/j.ajhg.2018.12.021. Epub 2019 Jan 31.

10.

Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top-Down Proteomics: A Pilot Study.

Molinari N, Roche S, Peoc'h K, Tiers L, Séveno M, Hirtz C, Lehmann S.

Front Mol Neurosci. 2018 Dec 18;11:477. doi: 10.3389/fnmol.2018.00477. eCollection 2018.

11.

Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword.

Peoc'h K, Manceau H, Karim Z, Wahlin S, Gouya L, Puy H, Deybach JC.

Mol Genet Metab. 2018 Oct 9. pii: S1096-7192(18)30482-7. doi: 10.1016/j.ymgme.2018.10.001. [Epub ahead of print]

PMID:
30413387
12.

Amended diagnostic protocol increases the early diagnosis of sporadic Creutzfeldt-Jakob disease.

Bizzi A, Peoc'h K.

Neurology. 2018 Jul 24;91(4):155-156. doi: 10.1212/WNL.0000000000005871. Epub 2018 Jun 22. No abstract available.

PMID:
29934422
13.

Characterization and origin of heme precursors in amniotic fluid: lessons from normal and pathological pregnancies.

Manceau H, Puy V, Schmitt CM, Gil S, Lefebvre T, Allaf B, Rosenblatt J, Gouya L, Puy H, Muller F, Peoc'h K.

Pediatr Res. 2018 Jul;84(1):80-84. doi: 10.1038/s41390-018-0011-2. Epub 2018 May 23.

PMID:
29795201
14.

High urinary ferritin reflects myoglobin iron evacuation in DMD patients.

Rouillon J, Lefebvre T, Denard J, Puy V, Daher R, Ausseil J, Zocevic A, Fogel P, Peoc'h K, Wong B, Servais L, Voit T, Puy H, Karim Z, Svinartchouk F.

Neuromuscul Disord. 2018 Jul;28(7):564-571. doi: 10.1016/j.nmd.2018.03.008. Epub 2018 Mar 20.

15.

Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.

Schmitt C, Lenglet H, Yu A, Delaby C, Benecke A, Lefebvre T, Letteron P, Paradis V, Wahlin S, Sandberg S, Harper P, Sardh E, Sandvik AK, Hov JR, Aarsand AK, Chiche L, Bazille C, Scoazec JY, To-Figueras J, Carrascal M, Abian J, Mirmiran A, Karim Z, Deybach JC, Puy H, Peoc'h K, Manceau H, Gouya L.

J Intern Med. 2018 Jul;284(1):78-91. doi: 10.1111/joim.12750. Epub 2018 Mar 26.

PMID:
29498764
16.

From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria.

Lenglet H, Schmitt C, Grange T, Manceau H, Karboul N, Bouchet-Crivat F, Robreau AM, Nicolas G, Lamoril J, Simonin S, Mirmiran A, Karim Z, Casalino E, Deybach JC, Puy H, Peoc'h K, Gouya L.

Hum Mol Genet. 2018 Apr 1;27(7):1164-1173. doi: 10.1093/hmg/ddy030.

PMID:
29360981
17.

Personalized medicine, pharmacogenomic and companion biomarker.

Manceau H, Amrani K, Peoc'h K.

Ann Biol Clin (Paris). 2017 Dec 1;75(6):631-636. doi: 10.1684/abc.2017.1306. Review.

PMID:
29192598
18.

Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far.

Peoc'h K, Nuzzo A, Guedj K, Paugam C, Corcos O.

Clin Chem Lab Med. 2018 Feb 23;56(3):373-385. doi: 10.1515/cclm-2017-0291. Review.

19.

Reform of the outside nomenclature biomedical tests in France: a two year review.

Peoc'h K, Lehmann S, Delpech M.

Ann Biol Clin (Paris). 2017 Aug 1;75(4):365. doi: 10.1684/abc.2017.1270. No abstract available.

PMID:
28751280
20.

[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases].

Magnin E, Dumurgier J, Bouaziz-Amar E, Bombois S, Wallon D, Gabelle A, Lehmann S, Blanc F, Bousiges O, Hannequin D, Jung B, Miguet-Alfonsi C, Quillard M, Pasquier F, Peoc'h K, Laplanche JL, Hugon J, Paquet C; pour le groupe ePLM (étude des biomarqueurs de la Ponction Lombaire Multicentrique).

Rev Med Interne. 2017 Apr;38(4):250-255. doi: 10.1016/j.revmed.2016.10.383. Epub 2016 Nov 24. Review. French.

PMID:
27890382
21.

Fecal calprotectin in inflammatory bowel diseases: update and perspectives.

Manceau H, Chicha-Cattoir V, Puy H, Peoc'h K.

Clin Chem Lab Med. 2017 Mar 1;55(4):474-483. doi: 10.1515/cclm-2016-0522. Review.

22.

Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.

Chaabouni T, Manceau H, Peoc'h K.

Ann Biol Clin (Paris). 2016 Aug 1;74(4):385-94. doi: 10.1684/abc.2016.1172. Review.

23.

Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.

Saint-Aubert L, Pariente J, Dumas H, Payoux P, Brandel JP, Puel M, Vital A, Guedj E, Lesage S, Peoc'h K, Brefel Courbon C, Ory Magne F.

BMC Neurol. 2016 Jul 30;16:122. doi: 10.1186/s12883-016-0643-y.

24.

GNPAT polymorphism rs11558492 is not associated with increased severity in a large cohort of HFE p.Cys282Tyr homozygous patients.

Tchernitchko D, Scotet V, Lefebvre T, L'Hostis C, Gourlaouen I, Merour MC, Rebah K, Peoc'h K, Assari S, Ferec C, Puy H, Le Gac G.

Hepatology. 2017 Mar;65(3):1069-1071. doi: 10.1002/hep.28742. Epub 2016 Oct 6. No abstract available.

PMID:
27474861
25.

Pre-examination factors affecting molecular diagnostic test results and interpretation: A case-based approach.

Payne DA, Baluchova K, Peoc'h KH, van Schaik RHN, Chan KCA, Maekawa M, Mamotte C, Russomando G, Rousseau F, Ahmad-Nejad P; IFCC Committee for Molecular Diagnostics (C-MD).

Clin Chim Acta. 2017 Apr;467:59-69. doi: 10.1016/j.cca.2016.06.018. Epub 2016 Jun 16.

PMID:
27321365
26.

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.

Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc'h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group.

J Alzheimers Dis. 2016;51(3):905-13. doi: 10.3233/JAD-151111.

PMID:
26890785
27.

[Porphyrias and haem related disorders].

Peoc'h K, Martin-Schmitt C, Talbi N, Deybach JC, Gouya L, Puy H.

Rev Med Interne. 2016 Mar;37(3):173-85. doi: 10.1016/j.revmed.2015.12.005. Epub 2016 Jan 7. Review. French.

PMID:
26774916
28.

A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.

Icick R, Peoc'h K, Karsinti E, Ksouda K, Hajj A, Bloch V, Prince N, Mouly S, Bellivier F, Lépine JP, Laplanche JL, Vorspan F.

Am J Addict. 2015 Oct;24(7):613-20. doi: 10.1111/ajad.12273. Epub 2015 Sep 1.

PMID:
26331953
29.

Multicentric evaluation of eight glucose and four ketone blood meters.

Guimont MC, Desjobert H, Fonfrède M, Vitoux D, Benoist JF, Launay JM, Peoc'h K, Lefèvre G.

Clin Biochem. 2015 Dec;48(18):1310-6. doi: 10.1016/j.clinbiochem.2015.07.032. Epub 2015 Jul 29.

PMID:
26232287
30.

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.

Dumurgier J, Schraen S, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc'h K, Sablonnière B, Kastanenka KV, Delaby C, Pasquier F, Touchon J, Hugon J, Paquet C, Lehmann S.

Alzheimers Res Ther. 2015 Jun 1;7(1):30. doi: 10.1186/s13195-015-0114-5. eCollection 2015.

31.

Genotyping test with clinical factors: better management of acute postoperative pain?

Hajj A, Peoc'h K, Laplanche JL, Jabbour H, Naccache N, Abou Zeid H, Yazbeck P, Khabbaz LR.

Int J Mol Sci. 2015 Mar 19;16(3):6298-311. doi: 10.3390/ijms16036298.

32.

Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.

Mouly S, Bloch V, Peoc'h K, Houze P, Labat L, Ksouda K, Simoneau G, Declèves X, Bergmann JF, Scherrmann JM, Laplanche JL, Lepine JP, Vorspan F.

Br J Clin Pharmacol. 2015 Jun;79(6):967-77. doi: 10.1111/bcp.12576.

33.

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.

Lehmann S, Dumurgier J, Schraen S, Wallon D, Blanc F, Magnin E, Bombois S, Bousiges O, Campion D, Cretin B, Delaby C, Hannequin D, Jung B, Hugon J, Laplanche JL, Miguet-Alfonsi C, Peoc'h K, Philippi N, Quillard-Muraine M, Sablonnière B, Touchon J, Vercruysse O, Paquet C, Pasquier F, Gabelle A.

Alzheimers Res Ther. 2014 Jun 26;6(3):38. doi: 10.1186/alzrt267. eCollection 2014.

34.

Study of blood and brain lithium pharmacokinetics in the rat according to three different modalities of poisoning.

Hanak AS, Chevillard L, El Balkhi S, Risède P, Peoc'h K, Mégarbane B.

Toxicol Sci. 2015 Jan;143(1):185-95. doi: 10.1093/toxsci/kfu224. Epub 2014 Oct 28.

PMID:
25354763
35.

KCNH2 polymorphism and methadone dosage interact to enhance QT duration.

Hajj A, Ksouda K, Peoc'h K, Curis E, Messali A, Deveaux LL, Bloch V, Prince N, Mouly S, Scherrmann JM, Lépine JP, Laplanche JL, Drici MD, Vorspan F.

Drug Alcohol Depend. 2014 Aug 1;141:34-8. doi: 10.1016/j.drugalcdep.2014.04.027. Epub 2014 May 14.

PMID:
24875677
36.

OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients.

Icick R, Peoc'h K, Ksouda K, Bloch V, Laplanche JL, Lépine JP, Bellivier F, Vorspan F.

Psychiatry Res. 2014 Aug 15;218(1-2):259-60. doi: 10.1016/j.psychres.2014.04.035. Epub 2014 Apr 24. No abstract available.

PMID:
24813900
37.

The screening of Alzheimer's patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trials.

Dumurgier J, Laplanche JL, Mouton-Liger F, Lapalus P, Indart S, Prévot M, Peoc'h K, Hugon J, Paquet C.

J Neurol. 2014 Jun;261(6):1187-95. doi: 10.1007/s00415-014-7335-6. Epub 2014 Apr 12.

PMID:
24728335
38.

Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.

Oustric V, Manceau H, Ducamp S, Soaid R, Karim Z, Schmitt C, Mirmiran A, Peoc'h K, Grandchamp B, Beaumont C, Lyoumi S, Moreau-Gaudry F, Guyonnet-Dupérat V, de Verneuil H, Marie J, Puy H, Deybach JC, Gouya L.

Am J Hum Genet. 2014 Apr 3;94(4):611-7. doi: 10.1016/j.ajhg.2014.02.010. Epub 2014 Mar 27.

39.

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc'h K, Rouaud O, Sablonnière B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S390-S394.e2. doi: 10.1016/j.jalz.2013.06.008. Epub 2013 Oct 23.

PMID:
24269268
40.

20 ans après: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition.

Piton A, Poquet H, Redin C, Masurel A, Lauer J, Muller J, Thevenon J, Herenger Y, Chancenotte S, Bonnet M, Pinoit JM, Huet F, Thauvin-Robinet C, Jaeger AS, Le Gras S, Jost B, Gérard B, Peoc'h K, Launay JM, Faivre L, Mandel JL.

Eur J Hum Genet. 2014 Jun;22(6):776-83. doi: 10.1038/ejhg.2013.243. Epub 2013 Oct 30.

41.

Can mu-opioid receptor A118G gene polymorphism be predictive of acute poisoning severity in the emergency department?

Peoc'h K, Megarbane B.

J Med Toxicol. 2013 Sep;9(3):292-3. doi: 10.1007/s13181-013-0317-8. No abstract available.

42.

Lexical fields of predictive and personalized medicine.

Mathieu T, Bermont L, Boyer JC, Versuyft C, Evrard A, Cuvelier I, Couderc R, Peoc'h K; Working Group of the Société française de biologie clinique (SFBC) “ Pharmacogénétique et médecine predictive”.

Drug Metabol Drug Interact. 2013;28(2):125-32. doi: 10.1515/dmdi-2013-0024. Review.

PMID:
23740683
43.

Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.

Hajj A, Khabbaz L, Laplanche JL, Peoc'h K.

Pharmacogenomics. 2013 Apr;14(5):575-85. doi: 10.2217/pgs.13.13.

PMID:
23556453
44.

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease.

Dumurgier J, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc'h K, Schraen S, Sablonnière B, Pasquier F, Touchon J, Lehmann S, Hugon J, Paquet C.

Neurobiol Dis. 2013 Jun;54:486-91. doi: 10.1016/j.nbd.2013.01.023. Epub 2013 Feb 13.

PMID:
23416172
45.

[Lexical fields of predictive and personalized medicine].

Mathieu T, Bermont L, Boyer JC, Versuyft C, Evrard A, Cuvelier I, Couderc R, Peoc'h K.

Ann Biol Clin (Paris). 2012 Nov-Dec;70(6):651-8. doi: 10.1684/abc.2012.0767. Review. French.

46.

Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study.

Gabelle A, Dumurgier J, Vercruysse O, Paquet C, Bombois S, Laplanche JL, Peoc'h K, Schraen S, Buée L, Pasquier F, Hugon J, Touchon J, Lehmann S.

J Alzheimers Dis. 2013;34(1):297-305. doi: 10.3233/JAD-121549.

PMID:
23186986
47.

Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting.

Dumurgier J, Vercruysse O, Paquet C, Bombois S, Chaulet C, Laplanche JL, Peoc'h K, Schraen S, Pasquier F, Touchon J, Hugon J, Lehmann S, Gabelle A.

Alzheimers Dement. 2013 Jul;9(4):406-13. doi: 10.1016/j.jalz.2012.06.006. Epub 2012 Nov 8.

PMID:
23141384
48.

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc'h K, Schelzke G, Karch A, van Duijn CM, Zerr I.

Brain. 2012 Oct;135(Pt 10):3051-61. doi: 10.1093/brain/aws238. Epub 2012 Sep 25.

49.

Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders.

Peoc'h K, Levavasseur E, Delmont E, De Simone A, Laffont-Proust I, Privat N, Chebaro Y, Chapuis C, Bedoucha P, Brandel JP, Laquerriere A, Kemeny JL, Hauw JJ, Borg M, Rezaei H, Derreumaux P, Laplanche JL, Haïk S.

Hum Mol Genet. 2012 Dec 15;21(26):5417-28. doi: 10.1093/hmg/dds377. Epub 2012 Sep 10. Erratum in: Hum Mol Genet. 2014 Apr 15;23(8):2234.

PMID:
22965875
50.

New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer's disease.

Rose C, Peoc'h K, Chasseigneaux S, Paquet C, Dumurgier J, Bourasset F, Calon F, Laplanche JL, Hugon J, Allinquant B.

BMC Neurosci. 2012 Jul 23;13:84. doi: 10.1186/1471-2202-13-84.

Supplemental Content

Loading ...
Support Center